Depression is highly prevalent in patients with cardiovascular disease, but questions about the effectiveness of screening and intervention remain unanswered. To evaluate the effects of proactive intervention at an acute-care heart and vascular hospital, patients who reported depressive symptoms on admission were randomized to an active, counseling-based depression intervention plus standard care (referral to a primary or psychiatric care physician) or to standard care alone. Despite early termination of patient enrollment because of lower-than-expected recruitment rates, the project had a positive impact. By involving and educating staff, the investigators raised awareness and improved the process of identifying and helping depressed patients. The lessons in study design and execution gained from this experience will help ensure success in future studies of this condition.
I
n 2008, the American Heart Association issued a science advisory recommending routine depression screening for patients with coronary heart disease. Soon after, Ziegelstein et al issued rebuttals labeling the recommendation "premature" and called on the American Heart Association to rescind the advisory owing to a lack of rigorously evaluated evidence demonstrating clear plans to benefi t patients through reasonable use of resources (1) . Th e risk of depression in cardiovascular patients and the worsened outcomes that result are clear, but screening remains controversial, as does the question of what intervention, if any, is a reasonable response to patients identifi ed as depressed. A 2006 study by Rieckmann et al demonstrated a 1% improvement in medication adherence for each point of improvement in the Beck Depression Inventory (BDI) score (2) , but studies showing improvement in other outcome measures are lacking. Investigators also have yet to identify a reproducible and reliable intervention that can improve depression scores and/or outcome measures in this particular population. With the goal of improving screening at a single high-volume acute-care cardiovascular hospital, a novel study was undertaken to compare depression screening tools in a population self-identifi ed to be at risk and to evaluate via randomized trial the potential effi cacy of a counseling-based intervention for those identifi ed with severe symptoms.
METHODS
To evaluate current screening methods, study personnel completed a random chart audit that examined the admis- sion database, a form fi lled out by patients upon admission. As shown in Figure 1 , the section of the form serving as the depression-screening tool asks two questions: Are you feeling hopeless or worthless? If yes, are you having thoughts of suicide or harming yourself? A review of 340 charts at the cardiovascular hospital over a 3-month period in the fall of 2008 revealed that 4.4% of the population (15 patients) had noted signs of depression on their admission database. Of those 15 patients, only 1 was referred to counseling (via the offi ce of the chaplain). Th e feelings of hopelessness and worthlessness expressed by the other 14 patients were not acted upon further, presenting an opportunity for improvement. (At the time, the chart review was undertaken solely to evaluate the magnitude of the problem, so no further attempt was made to interpret the demographic characteristics of the patients who reported depressive symptoms. In retrospect, this oversight represented a missed opportunity to learn more about this group.)
A high-profi le suicide at another facility further increased interest in intervention for at-risk patients, prompting development of a protocol to evaluate tools for identifying depressed patients and providing support in the cardiac acute-care setting.
Depression associated with cardiovascular disease can be multifaceted, making assessment and intervention more complicated. When a patient answers yes to the current question about feeling hopeless or worthless, it is unclear whether those feelings are due to depressive symptomatology. Patients with cardiovascular disease often feel fatigued for weeks and lack the energy to conduct routine activities, mimicking key symptoms of depression even when full criteria are not met.
Th e 16-question Quick Inventory of Depression Symptomatology (QIDS) questionnaire is a tool that enables staff to measure the severity of a patient's depression (3) . Although validated in multiple population subgroups, it had not been validated in the specifi c population of cardiovascular acute-care patients.
Th e objective of the pilot study was to clarify the association between the newer QIDS tool and the industry-standard Beck Depression Inventory revision 2 (BDI-II) and to classify the unique features of cardiovascular inpatients and their depressive symptomatology. Power calculations assuming prevalence of depression consistent with the audit described above determined that an enrollment of 120 patients would be needed for statistical signifi cance. Prior to any screening or enrollment, all protocols were approved by the hospital's institutional review board.
Inclusion criteria were admission to a single acute-care unit within the cardiovascular hospital, an affi rmative answer to feelings of hopelessness or worthlessness on the admission screening form, and duration of stay suffi cient for completion of all necessary study procedures. Exclusion criteria included preexistent psychiatric medications for depression or psychosis, a QIDS score >14 (risk exceeding that acceptable for this pilot study), inability to consent, and active suicidal or homicidal thoughts.
Enrolled patients were randomized to one of two groups in a 1:1 ratio (Figure 2) . Th e control group received the standard referral to their primary care physician or a mental health provider. Th ose randomized to the intervention group received referral to a physician or mental health provider, a 15-to 30-minute counseling session, a depression workbook, activity chart, and three follow-up calls over the course of 3 months. Both groups were asked to complete the BDI-II, a suicidality assessment (if they had not already done so) and a brief demographic questionnaire. Th ose who chose not to enroll were given a supportive visit, encouragement to follow up with a physician or mental health provider, an activity chart, and a depression workbook.
At the end of 3 months, participants in both groups were to be reassessed and asked to complete the QIDS, the BDI-II, the suicidality assessment, and the demographic questionnaire. All participants were also to be asked whether they followed up with a physician or mental health professional to address depression. Th e results from the two groups were to be compared to determine 1) which domains of depressive symptoms measured by the QIDS and the BDI-II reliably refl ected depression in cardiovascular patients and 2) whether the intervention was signifi cantly benefi cial in this population.
RESULTS
During initial enrollment (February 2011 to February 2012), 126 cardiovascular patients noted feelings of hopelessness or worthlessness on the admission database and were screened for inclusion. Enrollment did not occur at the anticipated rate. Of 126 patients screened, only 8 were enrolled, and 6 of the 8 dropped out of or withdrew from the study.
Obstacles to successful completion of the study included the complexity of the study design, insuffi cient dedicated research time for the primary investigator, diffi culty in scoring the QIDS, and the rapid fl ow of patients in the acute-care setting.
Th e study's ambitious and complex design-comparing the results from the two depression-screening tools and measuring whether or not patients followed up with a primary care or mental health provider-resulted in too many end goals for the small patient population. Likewise, scoring the QIDS was complicated; incorrect scoring occurred often and in some cases led to incorrect referrals. It was clear that if the QIDS were not used routinely, the tool itself would present an educational barrier to those trying to administer it.
Th e rapid fl ow of patients in the acute-care setting also impeded enrollment. In many cases, eligible patients had stays as short as 4 to 5 hours, making an enrollment process that took upwards of 90 minutes infeasible. Compounding this problem further, it was generally the case that patients could only be enrolled preprocedure because the lingering eff ects of anesthetic or sedative agents prohibited consent thereafter. Patients who stayed longer were easier to engage, but maintaining their privacy was a challenge. To be accurate, depression screening must Lessons learned from study of depression in cardiovascular patients in an acute-care heart and vascular hospital January 2013be done in private, but having staff members ask family or visitors to step out during this time is an awkward proposition.
To help overcome these enrollment obstacles, the institutional review board allowed the inclusion of patients on two additional fl oors in February 2012; nevertheless, the team was not able to increase the rate of enrollment. Administrative matters (i.e., team member transitions, new study and support personnel, and divided roles of the research investigators) further hampered successful enrollment.
DISCUSSION
Th e hospital's research council learned much from this experience, such as recognizing that the end goals were too numerous and that a study of this magnitude requires a research coordinator and a part-time chaplain/counselor to fulfi ll all the duties of the principal investigator. After the initial year of the study, enrollment was ended because the rate was insuffi cient to achieve the study goals. A new protocol was approved and will be implemented before the end of 2012.
Despite the inability to achieve the more mathematical goals of the project, a profound impact on depression was nonetheless produced. When the project was begun, many patients reporting hopelessness, worthlessness, or even suicidality were not seen or off ered any support. Since April 2009, however, over 1100 patients have received follow-up. Th is number includes not only depressed patients but also suicidal patients who have been identifi ed and helped with appropriate interventions, up to and including protective custody orders for those with immediate intent toward self-harm. In one such case, after further screening indicated that no true intent was evident, the protective order was removed and the patient was appropriately counseled about endof-life options such as palliative care and hospice. Th ough enrollment into the study proper failed to demonstrate improvements as intended, the very screening process for the study dramatically improved identifi cation of patients at risk for depression, their transition to appropriate followup, and in several cases, the ultimate outcome of their situation.
Th is research project, in its development and even in its failure to achieve its targeted endpoints, demonstrated an ongoing need to improve the routine screening and intervention process for depressed inpatient populations. Ziegelstein et al raised concerns about screening being imprecise (1), and the current admission screen fi ts that description. Th e fi rst question-Are you feeling hopeless or worthless?-identifi es specifi c depressive symptoms but does not eff ectively measure their timing or severity, two key elements in the diagnosis of depression.
None of the screening tools used in the study were ideal. Although the QIDS indicates timing and severity of depression, its time-consuming administration and scoring diffi culty were prohibitive. Th e BDI-II, used only for validating the QIDS in the cardiovascular inpatient setting, was easier to score but was never considered for routine use because it was expensive and time-consuming to administer.
Th e Patient Health Questionnaire (PHQ), recommended by the American Heart Association, facilitates a self-rated, twostep approach to assessment. Th e fi rst two questions (PHQ-2) serve as a basic screen; if the patient scores above threshold, the remaining seven questions are also asked (PHQ-9). In a study published in 2010, investigators used this approach in a large inpatient cardiac setting and found that the PHQ was highly desirable for depression screening (4) . Th e instrument off ers the benefi ts of simple scoring, quick administration, public domain access, and easy transition from the short version (PHQ-2) to the more specifi c full instrument (PHQ-9).
Th e ideal screen would be normalized for patients in a cardiovascular inpatient setting, a feature lacking in currently available instruments. Indeed, the inadequacy of our current screening is illustrated by the fact that patients who express feelings of hopelessness or worthlessness on the morning of admission often indicate no such feelings after their procedure (e.g., after percutaneous coronary intervention). Furthermore, even statistically reliable instruments may have limitations in this population. Th e QIDS, for example, includes questions about sleep patterns and energy level, indicators of depression that are also intimately related to cardiovascular illness. Likewise, none of the screening tools refl ect chronic pain, recent bereavement, or substance use, among other situational aspects of the patient history. Yet, these factors may also fi gure prominently in the cardiovascular profi le (5) . As a result of the lessons learned from the initial protocol, the new research protocol features a simpler goal: to compare the current depression-screening questions to the PHQ-2 (for basic screening) and PHQ-9 (for follow-up screening). Th ere is no intervention arm in the new protocol, and the hypothesis is straightforward: the PHQ will generate referrals more accurately than the current screen. Th e team hopes that revising the admission database questions will better identify depressed patients and improve the rate of follow-up, thereby improving depressionscreening outcomes and overall patient outcomes. Th e Table compares the formats and features of the current screen, the QIDS, the PHQ, and an ideal future tool yet to be developed.
Further recommendations include involving a dedicated study coordinator with experience in behavioral research to optimize effi ciency of study execution. A study-specifi c script to ensure that staff members pursue patient privacy in an appropriate and consistent manner could help further streamline the process and decrease staff reservations about engaging patients in these sensitive aspects of their care.
Work within Baylor Health Care System also continues in parallel projects. Baylor All Saints Medical Center in Fort Worth, Texas, instituted a two-step intervention for all postpartum patients prior to discharge consisting of mandatory nursepatient counseling (in which a nurse discusses postpartum depression and its signs and symptoms) and a take-home brochure about the condition. Th e outcomes of this intervention were presented at the 2007 Nursing Quality Summit and served as an inspiration for the present project.
In conclusion, the fi eld of depression research among cardiovascular patients remains in a primal stage of development. No study need engage ambitious and far-reaching goals to make major contributions in this fi eld. Each step brings us closer to an eff ective program of screening and intervention and truly has the power to help save lives. Our work in this matter will begin anew to help take these smaller steps forward, and we hope our experience will help other centers to develop plans, tools, and techniques to do the same.
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